EX-99.1 2 ss215897_ex9901.htm JOINT FILING AGREEMENT

Exhibit 1

JOINT FILING AGREEMENT

                 

 The undersigned hereby agree that the Amendment No. 2 to Schedule 13D, dated April 7, 2021, with respect to the ordinary shares of Turning Point Therapeutics, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Each of the undersigned agrees to be responsible for the timely filing of this Statement, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

    

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the 7th day of April 2021.

 

  ORBIMED ADVISORS LLC  
       
       
  By: /s/ Jonathan Silverstein  
    Name: Jonathan Silverstein  
    Title: Member  
       
  ORBIMED CAPITAL GP VI LLC  
       
  By: ORBIMED ADVISORS LLC, its managing member
       
  By: /s/ Jonathan Silverstein  
    Jonathan Silverstein  
   

Title: Member of OrbiMed Advisors LLC

 

  
  ORBIMED CAPITAL LLC  
       
  By: /s/ Jonathan Silverstein  
    Jonathan Silverstein  
    Title: Member